
Sign up to save your podcasts
Or


Axel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can impact an academic career.
By The Uromigos4.9
5555 ratings
Axel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can impact an academic career.

139 Listeners

318 Listeners

699 Listeners

499 Listeners

14 Listeners

58 Listeners

2,445 Listeners

3,348 Listeners

9,188 Listeners

196 Listeners

512 Listeners

2 Listeners

34 Listeners

189 Listeners

2 Listeners